Delivery Order SPE2DB20D2104-SPE2DB23FS22U
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Eliquis 5 mg tablets. The contract is a Delivery Order valued at $12,438.18 with a period of performance through June 26, 2024. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as the primary vehicle for...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the provision of Eliquis 5 mg tablets. The contract, valued at $30,734.03, is a delivery order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which has a ceiling value of $999,999,999 and runs through November 2026. This IDC serves as a primary vehicle for AmerisourceBergen to supply a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide Eliquis 5 mg tablets. The $13,033.91 firm-fixed-price delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical division. This IDC serves as a primary vehicle for supplying a comprehensive range of pharmaceutical products and medical supplies to support...
- This federal contract award, valued at $11,936.77, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, which is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999, covers the supply of Eliquis 5 mg tablets for a period ending on March 19, 2024. This contract supports the healthcare needs of military personnel, veterans, and other federal...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,054.30 firm fixed-price delivery order contract is for the supply of Eliquis 5 mg tablets. It is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical supplies to...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,044.40 firm fixed-price delivery order contract, which runs through December 31, 2024, is for the provision of Eliquis 5 mg tablets. This contract award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as a vehicle...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,809.67 firm fixed-price delivery order is for the supply of Eliquis 5 mg tablets. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Eliquis 5 mg tablets. The contract, valued at $22,830.55, is a Firm Fixed Price Delivery Order that runs through October 2024. The award is not associated with a set-aside designation, indicating open competition. AmerisourceBergen, as the prime contractor, will provide the medication to support military treatment facilities,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of Eliquis 5mg tablets in quantities of 60. The $9,455.28 contract represents a Delivery Order placed against AmerisourceBergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for...
- This federal contract award, valued at $2,184.87, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order under Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB23FS22UDelivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Eliquis 5 mg tablets. The award, valued at $2,653.58, is a delivery order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which has a ceiling value of $999,999,999 and runs through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen is the prime contractor, and the contract supports the healthcare needs of military personnel, veterans, and other federal beneficiaries through a streamlined, comprehensive contracting mechanism.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.7k | 2/15/23 |